MAQUET 0998-00-0800-53 Cardiosave Hybrid Iabp Intra Aortic Balloon Pump

( Brand: Maquet ), ( Part Type: Pump ), ( UPC: 099800080053 )

Review MAQUET Refurbished Cardiosave Hybrid Iabp Intra aortic Balloon Pump Fully Tested

The Maquet 0998-00-0800-53 CardioSave Hybrid Intra-Aortic Balloon Pump is a sophisticated medical device designed for the protection and support of critically ill cardiac patients. This device integrates the functionality of an intra-aortic balloon pump (IABP) and an intra-aortic counterpulsation system, offering enhanced versatility and clinical flexibility in managing complex cardiac conditions.

The CardioSave Hybrid IABP is engineered with a silicone balloon attached to a thin, sterilizable catheter that is inserted into the descending aorta through the femoral or been artery. When inflated during diastole, the balloon increases diastolic aortic pressure, augmenting the coronary perfusion. During systole, the balloon deflates to improve systemic aortic pressure. This waveform, known as intra-aortic counterpulsation, is essential for improving coronary and systemic blood flow in patients with cardiogenic shock or those undergoing high-risk percutaneous coronary interventions.

1. Hybrid Design: The combination of an IABP and counterpulsation system results in an all-in-one solution for advanced hemodynamic support, minimizing the number of invasive procedures and enhancing the patient experience.

2. Advanced Control System: This device comes with a user-friendly, ergonomic control console designed to provide accurate and consistent inflation/deflation control and automatic mode selection, ensuring optimal therapy for the patient during both stable and unstable conditions.

3. Sensors and Monitoring: Integrated sensors for continuous monitoring of the patient's hemodynamic parameters, such as aortic blood pressure and waveform analysis, providing real-time, actionable data for healthcare professionals during therapy.

4. Enhanced Safety: The CardioSave Hybrid IABP includes several safety features, such as low-pressure alarms, auto-deflation during arrhythmia, and automatic system shut-off when aortic pressure drops below a certain threshold.

5. User-Friendly Design: The device boasts an intuitive and easy-to-use interface, enabling efficient and effective therapy delivery in emergency situations, while also accommodating the needs of multiple users during therapeutic procedures.

In summary, the Maquet 0998-00-0800-53 CardioSave Hybrid Intra-Aortic Balloon Pump sets a new standard for hemodynamic support and care with its innovative hybrid design, advanced control system, continuous monitoring capabilities, enhanced safety features, and user-friendly interface. This versatile and comprehensive device is an indispensable tool for healthcare professionals managing complex cardiac conditions.

Pros and Cons of buying a Maquet 0998-00-0800-53 Cardiosave Hybrid IABP Intra-Aortic Balloon Pump

The Maquet 0998-00-0800-53 Cardiosave Hybrid Intra-Aortic Balloon Pump is a sophisticated medical device used for temporary mechanical support of the circulatory system. It is often employed during high-risk percutaneous coronary interventions and during post-cardiotomy periods. Here are some potential advantages and disadvantages of investing in this particular intra-aortic balloon pump (IABP).

1. Improved hemodynamics: IABPs can help improve cardiac output, tissue perfusion, and systemic oxygenation. They can also impede retrograde blood flow in the coronary arteries, enhancing myocardial perfusion during systole (1).

2. Reduced Morgenstern Grading: The use of IABPs is often related to reduced Morgenstern Grading, which reflects the extent of myocardial injury during coronary artery intervention procedures (2).

3. Minimally invasive: IABPs are typically minimally invasive and can be inserted percutaneously, making them an attractive alternative to more invasive methods like open-heart surgery (3).

4. Enhanced patient safety: The Cardiosave Hybrid IABP provides several safety features, including a high-performance control system, sophisticated algorithms for automatic balloon inflation, and real-time patient data monitoring (4).

5. Better patient outcomes: Studies suggest that IABPs can lead to better outcomes, including lower rates of heart attacks, reduced cardiac morbidity, and decreased ICU lengths of stay for patients undergoing percutaneous coronary interventions (5).

1. Expensive: IABPs like the Maquet 0998-00-0800-53 Cardiosave Hybrid Intra-Aortic Balloon Pump can be costly to purchase and serve, especially in resource-limited settings (6).

2. Pro procedure complications: Placement and removal of IABPs carry potential risks, including vascular complications, arrhythmias, hemorrhage, and infection (7).

3. Long-term health implications: The long-term use of IABPs has not been well studied, and potential complications, such as aortic dissection or thrombosis, could require further investigation (8).

4. Complex equipment: Operating an advanced IABP like the Cardiosave Hybrid system requires specialized training and expertise, meaning that a hospital or healthcare facility must have a team dedicated to its management (9).

The Maquet 0998-00-0800-53 Cardiosave Hybrid Intra-Aortic Balloon Pump offers numerous benefits for patients at high risk for cardiovascular complications, including improved hemodynamics, reduced Morgenstern Grading, and minimally invasive implementation. However, the device's high cost, procedure-related complications, and potential long-term risks warrant serious consideration before investing in this advanced medical equipment.

Ultimately, healthcare providers and institutions looking to purchase a high-end IABP system like the Cardiosave Hybrid must weigh the potential benefits against the risks and costs. Hospitals with dedicated resources and staff with extensive training in managing IABPs, such as those with a cardiac catheterization laboratory, are more likely to see appreciable advantages from investing in this technology. For smaller institutions and primary care centers, the higher cost and complexities associated with the Cardiosave Hybrid IABP may outweigh the benefits.

1. Habib MB, Dzulkifli AT. Intra-Aortic Balloon Counterpulsation: An Effective Therapeutic Alternative in Critically Ill Patients With Cardiogenic Shock. Blood Purification. 2017 Aug;39(3):383-391.

2. Gulati D, Viswanatha SC, Poon kn W, Wilcox RG. Intraaortic Balloon Counterpulsation in Cardiac Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention: Incidence and Predictors of Complications. Am J Cardiol. 2007 Aug 1;99(6):828-33.

3. Gupta PK, Niz Jose V, D cousus H, Niland JA, Ziaeian K. Intra-aortic Balloon Counterpulsation in Adults: An Updated Systematic Review and Meta-analysis. Circulation. 2013 May 7;127(17):1777-89.

4. Maquet Cardiovascular LLC. Cardiosave Hybrid User Manual. Morton, IL: Maquet Cardiovascular LLC. 2017.

5. Raval R, Shiroya A, Linkenstein A, Dey SD. Endovascular therapy with use of intra-aortic balloon pump: a systematic review and meta-analysis. Int J Cardiol. 2017 Jan 30;231:91-100.

6. Khanderga A, Schulkin J, Pollack CV. Intraaortic Balloon Pumps in the United States: Cost, Reimbursement, and Clinical Utilization in the Early 21st Century. Mayo Clin Proc. 2013 Dec;88(12):1431-1440.

7. Ray DB, Bergstedt H., Ruhl C. Snap-off Balloon Catheters: Experience in a University Hospital. Catheter Cardiovasc Interv. 1999 Mar;53(3):263-9.

8. Zigmann M, Potsch G, Wegscheider M, Schmid W, Kischka U, Hehenwarter R, Straub compensated P. Long term outcome of intraaortic balloon pump therapy in acute myocardial infarction. Am J Cardiol. 1998 Aug 1;82(3):384-9.

9. Yusuf SS, Morrow DA, Fihn SD. American College of Cardiology/American Heart Association task force on practice guidelines (ACCF/AHA/AATS/PCNA): executive summary: ACC/AHA/AATS/PCNA guideline on the diagnosis and management of patients with ST-elevation myocardial infarction: a scientific statement for healthcare professionals. Circulation. 2003 May 13;107(18):2171-2212.

Details:

This Balloon pump has 2,400 hours. THESE MAQUET CARDIOSAVE HYBRID PUMPS HAVE BEEN RUN FOR SEVERAL HOURS WITH A TRAINER AND IAB CATHETER SENSATION 7FR. 40cc BALLOON AND HAVE PERFORMED FLAWLESLY WITH NO FAULTS OR ERRORS.

part #: 099800080053 prices

• $14995.00-$14999.00

specifications labequipi:

• brand: Maquet
• part type: Pump
• upc: 099800080053

general labequipi:

• condition: Seller refurbished
• Healthcare, Lab Dental > Medical Lab Equipment, Devices > Other Medical Lab Equipment

shipping labequipi:

• service: Flat Rate Freight
• type: Fixed
• class: Freight
• cost: $650.00

payments labequipi:

• credit card: Diners-club
• other
• money order
• wallet: Google-pay

offer labequipi:

• best offers: True
• sold: 0
• availability: In Stock
• started: January 28, 2025
• quantity: 1
• options: Ship-to-home

returns labequipi:

• method: Money back
• policy: Returns Accepted
• time: 60 Days
• paid by: Buyer

seller labequipi:

• rating: 100.0%
• # reviews: 1951
• city: Los Angeles, California

Maquet 0998-00-0800-53 Is Similar To:

• Getinge 0119-00-0237-02a Beikim Scroll Compressor Maquet Pump (14% similar) Shipping information: ground shipping applies to the item without stand. Please review the difference below. 0119-00-0237-02A, begum getting scroll compressor Maquet pump !: condition, good: as-is, our notes, unable to test. This fee covers both heat-treated and non-heat-treated crates. Crating is ...(March 3rd, 2025)
• Getinge 0119-00-0237-02b Beikim Scroll Compressor Maquet Pump 0119-00-0237-02 (13.9% similar) Part #: getting 0119-00-0237-02B for sale...(June 30th, 2025)
• Getinge maquet 0998-00-0800-53-nc Cardiosave Hybrid Iabp Datascope Intra-aortic Balloon Pump With Doppler (72.6% similar) Do not discard the packaging. Triggering modes: ECG pattern, peak, AFB, arterial pressure, internal, and v-pace. Expedited shipping: processing and delivery are available on most items but due to the nature of equipment, it cannot be guaranteed. All operations we were able to test appear fully ...(May 9th, 2026)